Skip to main content

Table 1 Clinical and demographic data

From: Lipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic pancreatitis

  HP
N = 24
HTG
N = 31
p
Age (years) 43 ± 11 46 ± 9 NS
Age first onset AP 40 ± 11 -  
AP Episo N° 2.3 ± 1.9 (1–9)   
1epis 9 (37.5%)   
2epis 9 (37.5%)   
≥ 3 epis 6 (25%)   
Sex (Men) 21 (90%) 28 (87%) NS
Smokers 15 (62%) 19 (61%) NS
Alcohol users 12 (50%) 17 (55%) NS
AF 13 (54%) 13 (42%) NS
BMI (kg/m2) 26.5 ± 4.0 29.3 ± 5.0 0.03
<25 10 (42%) 4(13%)  
25–30 10 (42%) 14 (45%)  
>30 4 (17%) 13 (42%)  
Diet only 11 (45%) 8 (26%)  
Fibrates 13 (54%) 18 (58%)  
Niacin 1 (4%) 0 NS
Fish oils 0 5 (16%)  
Statins 1 (4%) 4 (13%)  
Comorbidities    
Diabetes 7 (29) 9 (29) NS
Hypertension 5 (21) 13 (42) 0.052
Fatty Liver 5 (21) 9 (29) NS
Vascular disease 3 (12) 5 (16) NS
Coronary artery disease 1 (4) 5 (16) NS
  1. AP: acute pancreatitis. AF: positive family history.
  2. HP : hypertriglyceridaemic pancreatitis; HTG: severe hypertriglyceridaemia;